本页面由Tiger Trade Technology Pte. Ltd.提供服务

Pasithea Therapeutics Corp.

0.4238
-0.0237-5.30%
盘后:0.42380.00000.00%16:04 EDT
成交量:6.00万
成交额:2.54万
市值:1,416.10万
市盈率:-0.29
高:0.4500
开:0.4500
低:0.4100
收:0.4475
52周最高:2.06
52周最低:0.2810
股本:3,341.44万
流通股本:1,020.20万
量比:0.76
换手率:0.59%
股息:- -
股息率:- -
每股收益(TTM):-1.4820
每股收益(LYR):-2.9100
净资产收益率:-65.49%
总资产收益率:-36.00%
市净率:0.28
市盈率(LYR):-0.15

数据加载中...

2022/07/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/29

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/27

重要事件披露

8-K/A [Amend] - Current report
2022/06/24

重要事件披露

8-K - Current report
2022/06/24

重要事件披露

8-K/A [Amend] - Current report
2022/06/22

重要事件披露

8-K - Current report
2022/06/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/10

重要事件披露

8-K - Current report
2022/06/01

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/05/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/12

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/21

重要事件披露

8-K - Current report
2021/12/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/14

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/09

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933